⌘K

Login Start Free

Home/Filings/4/0001415889-25-016226

4//SEC Filing

Torres Denice 4

Accession 0001415889-25-016226

CIK 0000744218other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:12 PM ET

Size

5.8 KB

Accession

0001415889-25-016226

Insider Transaction Report

Form 4

Period: 2025-06-05

Celldex Therapeutics, Inc.CLDX

Director

Transactions

Award
Non-Qualified Stock Option (right to buy)
2025-06-05+33,000→ 33,000 total
Exercise: $19.53Exp: 2035-06-05→ Common Stock (33,000 underlying)

Footnotes (2)

[F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
[F2]Such option vests in three equal annual installments beginning June 5, 2026.

Documents

1 file

4
form4-06092025_080642.xmlPrimary

Issuer

Celldex Therapeutics, Inc.

CIK 0000744218

Entity typeother

Related Parties

1

filerCIK 0001820278

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 4:12 PM ET
Size: 5.8 KB

View on SEC.gov